Creative Planning

Position in ONCY — Oncolytics Biotech Inc

CIK 1540235 OVERLAND PARK, KS

Position in ONCY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$12,825

+$462 QoQ

Shares Held

13,500

-7.2% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#43

of 74 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. ONCY ranks #215 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,672	$63,418,511
2	REGN	Regeneron Pharmaceuticals, Inc.	36,949	$23,039,178
3	EXEL	Exelixis, Inc.	270,292	$14,706,586
4	INCY	Incyte Corp	110,664	$12,544,870
5	CYTK	Cytokinetics Inc	141,939	$12,091,783
6	RVMD	Revolution Medicines, Inc.	64,120	$12,008,393
7	ARGX	Argenx SE	12,744	$11,823,500
8	BMRN	Biomarin Pharmaceutical Inc	153,161	$8,763,872

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,825	13,500	-7.2%	Shares	Sole	2026-08-13
2026-03-31	$12,363	14,545	+9.1%	Shares	Sole	2026-05-12
2025-12-31	$11,597	13,330	0.0%	Shares	Sole	2026-02-17
2025-09-30	$18,662	13,330	0.0%	Shares	Sole	2025-11-14
2025-06-30	$10,264	13,330	0.0%	Shares	Sole	2025-08-08
2025-03-31	$7,331	13,330	0.0%	Shares	Sole	2025-05-15
2024-12-31	$12,130	13,330	+29.0%	Shares	Sole	2025-02-14
2024-09-30	$8,987	10,330	-93.9%	Shares	Sole	2024-10-11
2021-03-31	$647,700	170,000	-5.6%	Shares	Sole	2021-04-30
2020-12-31	$428,400	180,000	+5.9%	Shares	Sole	2021-01-29
2020-09-30	$287,300	170,000	+54.5%	Shares	Sole	2020-11-05
2020-06-30	$206,800	110,000	+18.3%	Shares	Sole	2020-07-23
2020-03-31	$128,340	93,000	—	Shares	Sole	2020-05-05
No filing history on record for this holder in this stock.